INHIBITION OF HUMAN CYTOMEGALOVIRUS DNA-REPLICATION WITH A PHOSPHOROTHIOATE CHOLESTERYL-MODIFIED OLIGONUCLEOTIDE IS MEDIATED BR BY RAPID CELLULAR-ASSOCIATION AND VIRUS-FACILITATED NUCLEAR-LOCALIZATION
Z. Zhang et al., INHIBITION OF HUMAN CYTOMEGALOVIRUS DNA-REPLICATION WITH A PHOSPHOROTHIOATE CHOLESTERYL-MODIFIED OLIGONUCLEOTIDE IS MEDIATED BR BY RAPID CELLULAR-ASSOCIATION AND VIRUS-FACILITATED NUCLEAR-LOCALIZATION, Antiviral chemistry & chemotherapy, 8(3), 1997, pp. 255-264
We have previously shown that an antisense phosphorothioate (PS) oligo
deoxynucleotide has potent anti-human cytomegalovirus (HCMV) activity
(GS Pari, AK Field & JA Smith, Antimicrobial Agents and Chemotherapy 1
995, 39: 1157-1161). We have now used a modified PS oligonucleotide ha
ving three 2'-O-methyl nucleotides at the 3' end and four 2'-O-methyl
nucleotides at the 5' end, containing a cholesteryl moiety linked to t
he 3' end by a novel thiono-triester linkage. This compound, UL36ANTI-
M, is superior to the PS (UL36ANTI) version with respect to antiviral
potency, melting temperature and nuclease resistance. Also, we show th
at cellular association for this oligonucleotide is rapid, occurring w
ithin 15 min after treatment and is about 12-fold higher when compared
to UL36ANTI. This increased rate of cellular association also correla
tes with antiviral properties in that a 15 min incubation with UL36ANT
I-M was sufficient to achieve 75% inhibition of viral DNA replication
and complete inhibition was achieved after only a 1 h pretreatment. In
addition confocal microscopic examination showed a change in subcellu
lar distribution from perinuclear to nuclear for oligonucleotides in H
CMV-infected human fibroblasts. However, the total amount of cell-asso
ciated oligonucleotide was unchanged in infected cells.